Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
- R. Dworkin, D. Turk, +37 authors S. Zavisic
- Medicine
- The journal of pain : official journal of the…
- 1 February 2008
UNLABELLED
A consensus meeting was convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to provide recommendations for interpreting clinical importance… Expand
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.
- R. Dworkin, A. O’connor, +19 authors C. D. Wells
- Medicine
- Mayo Clinic proceedings
- 1 March 2010
The Neuropathic Pain Special Interest Group of the International Association for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacological treatment of… Expand
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
BACKGROUND
The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus… Expand
A method for assessing drug therapy appropriateness.
- J. Hanlon, K. Schmader, +5 authors J. Feussner
- Medicine
- Journal of clinical epidemiology
- 1 October 1992
This study evaluated the reliability of a new medication appropriateness index. Using the index, independent assessments were made of chronic medications taken by 10 ambulatory, elderly male patients… Expand
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
- R. Dworkin, M. Backonja, +18 authors S. Weinstein
- Medicine
- Archives of neurology
- 1 November 2003
Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system, comes in many forms. We describe current approaches to the diagnosis and assessment of neuropathic pain and… Expand
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
- E. Corder, A. Saunders, +11 authors M. Pericak-Vance
- Biology, Medicine
- Nature Genetics
- 1 June 1994
Gene dosage of the apolipoprotein E (APOE) ε4 allele is a major risk factor for familial Alzheimer disease (AD) of late onset (after age 60). Here we studied a large series of 115 AD case subjects… Expand
Recommendations for the management of herpes zoster.
- R. Dworkin, R. Johnson, +20 authors R. Whitley
- Medicine
- Clinical infectious diseases : an official…
- 2007
The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on… Expand
An Interdisciplinary Expert Consensus Statement on Assessment of Pain in Older Persons
- T. Hadjistavropoulos, K. Herr, +24 authors J. Williams
- Medicine
- The Clinical journal of pain
- 1 January 2007
This paper represents an expert-based consensus statement on pain assessment among older adults. It is intended to provide recommendations that will be useful for both researchers and clinicians.… Expand
Appropriate prescribing in elderly people: how well can it be measured and optimised?
- A. Spinewine, K. Schmader, N. Barber, Carmel Hughes, J. Hanlon
- Medicine
- The Lancet
- 14 July 2007
Prescription of medicines is a fundamental component of the care of elderly people, and optimisation of drug prescribing for this group of patients has become an important public-health issue… Expand
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
- K. Schmader, M. Levin, +12 authors J. Parrino
- Medicine
- Clinical infectious diseases : an official…
- 1 April 2012
BACKGROUND
Herpes zoster (HZ) adversely affects individuals aged 50-59, but vaccine efficacy has not been assessed in this population. This study was designed to determine the efficacy, safety, and… Expand